Unity Biotechnology, Inc.·4

Dec 15, 4:44 PM ET

Dananberg Jamie 4

4 · Unity Biotechnology, Inc. · Filed Dec 15, 2022

Insider Transaction Report

Form 4
Period: 2022-12-14
Dananberg Jamie
Chief Medical Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2022-12-14$2.85/sh1,016$2,89665,105 total
Footnotes (3)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.
  • [F3]Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION